Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
2019 second quarter results announcement
We will announce our second quarter 2019 results at 12:00 BST, 07:00 EDT on Wednesday 24 July.
Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Iain Mackay, CFO; and Hal Barron, Chief Scientific Officer and President, R&D at 14:00 BST, 09:00 EDT.